SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (1985)5/2/2003 6:54:41 PM
From: Icebrg  Read Replies (1) of 2243
 
>> Spectrum Pharmaceuticals (SPPI)>>

And while I am touching on the combination of moon-shots and Dr Tracy. Our NeuroInvestor also suggested - in the May issue reviewing current and potential future schizophrenia treatments - that Spectrum might salvage some parts of the left-overs from Dr. Glasky's NeoTherapeutic's era. In this particular case NEO-356 for which compound there appears to be some in-licensing interest from a couple of midsize pharma types.

Any such move would of course be of immense interest to Spectrum (market cap. 6 mUSD) and its shareholders. In Spectrum's situation every dollar will count. De-listing is still a very real threat.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News